US EditionProstate cancer treatment with potential for fewer side effects to be trialled in UK
The trial will recruit 280 patients globally to assess if Aquablation reduces side effects like erectile dysfunction compared to radical prostatectomy, improving quality of life, researchers said.
- In the UK, a NIHR-backed trial has launched to test Aquablation against radical prostatectomy, with the Royal Marsden in London first to recruit and Procept BioRobotics sponsoring across three countries.
- Because radical prostatectomy can cause serious side-effects such as infection and erectile dysfunction, researchers and consultant urological surgeons are testing Aquablation to minimise these risks and preserve continence and sexual activity.
- Using a robotic high-pressure waterjet, Aquablation lets surgeons employ real-time ultrasound mapping and AI guidance to remove cancerous tissue while sparing nerves and muscles, and is used for benign prostatic hyperplasia .
- The trial will recruit 280 patients worldwide with early-stage, localised prostate cancer, enrolling at more than 25 centres including Royal Marsden, Guy's and St Thomas' NHS Foundation Trust, Royal Free London NHS Foundation Trust, and Norfolk and Norwich University Hospitals NHS Foundation Trust.
- Following the UKNSC draft, Health Secretary Wes Streeting said earlier this week he was surprised that experts expect data within two years from a Prostate Cancer UK trial combining PSA test and rapid MRI, and Aquablation could add a global alternative surgical option.
15 Articles
15 Articles
Evening Standard
Trial for prostate cancer treatment with fewer side-effects launches in UK
The treatment is suitable for men whose cancer has not spread outside of the prostate gland or has spread to the area just outside the gland.
News in brief: Robotic surgery training in Cambridge, AI and imaging prostate cancer trial at Royal Marsden, VR initiative at Portsmouth Hospitals – HTN Health Tech News
We’re taking a look at some of the stories that have caught our eye over the last few weeks, with a focus on robotic surgery, AI, imaging, VR, and other emerging technologies. New training centre focuses on AI, extended reality, and robotic surgery at Cambridge University Hospitals Cambridge University Hospitals NHS Foundation Trust is celebrating the launch of the Cambridge Digital Health and Surgical Training Centre, set to offer high-tech fac…
Researchers say a 'groundbreaking' new trial for prostate cancer treatment has been launched in the UK.
Experts are hopeful Aquablation could minimise the risk of side effects from surgery. 280 patients are being recruited globally to take part - including from The Royal Marsden in Sutton. Philip Charlesworth is a consultant there, and explains how it works. https://audioboom.com/posts/8815567-philip-charlesworth-a-consultant-at-the-royal-marsden-in-sutton
Coverage Details
Bias Distribution
- 43% of the sources lean Left, 43% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
